-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Uncommon Histiocyte Disorders: Rosai-Dorfman Disease, Juvenile Xanthogranuloma, and Erdheim-Chester Disease

Program: Education Program
Session: Recent Advances in Histiocytic Neoplasms
Saturday, December 5, 2015, 2:00 PM-3:30 PM
W230, Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 9:30 AM-11:00 AM
W331, Level 3 (Orange County Convention Center)

Julien Haroche, MD, PhD

Institut E3M, Groupe Hospitalier Pitié-Salpêtrière, Paris, Paris, France

Disclosures: Off Label Use: vemurafenib (zelboraf) interferon alpha, pegylated interferon alpha.

See more of: Recent Advances in Histiocytic Neoplasms
See more of: Education Program
<< Previous Presentation | Next Presentation